This information was published on 2024-12-26T00:10:09 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2469207 |
| (220) |
25 Jul 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders |
| (540) | AUSTEDO XR |
| (550) | Word |
| (730) |
Auspex Pharmaceuticals, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.